Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Universe Pharmaceuticals INC
UPC | US
3.62
USD0.35
10.79%
UPC | US
Loading StockChartView...
About Universe Pharmaceuticals INC
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
08/06/2026
Close
3.62
Open
3.18
High
3.62
Low
2.97
Universe Pharmaceuticals INC a pharmaceutical company engages in the development manufacturing marketing distribution and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers including biomedical drugs medical instruments traditional Chinese medicine pieces products and dietary supplements. Its customers include pharmaceutical companies hospitals clinics and drugstore chains. The company was incorporated in 2019 and is headquartered in Ji'An China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
View LessUPC | US
Risk
113.5
Sharpe
-0.14
Luna's Score
48/100
Recommendation
Hold
Luna says (UPC | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
146.1%1 month
113.5%3 months
97.7%6 months
107.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.36
Debt to equity
0.24
Debt to assets
0.13
Ent. to EBITDA
0.31
Ent. to rev.
0.18
PEG
-
Other Fundamentals
EBITDA
-4.92M
MarketCap
85.67M
MarketCap(USD)
85.67M
Div. yield
-
Op. margin
-13.51
Erngs. growth
-82.00
Rev. growth
-30.20
Ret. on equity
-50.22
Short ratio
0.09
Short perc.
1.89
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.03
Range1M
1.12
Range3M
1.62
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
3.98
Price X volume
130.79K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.31 | 24.85 | Cheaper |
| Ent. to Revenue | 0.18 | 361.91 | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 0.36 | 13.15 | Cheaper |
| Dividend Yield | - | 2.94 | - |
| Std. Deviation (3M) | 97.73 | 65.24 | Riskier |
| Debt to Equity | 0.24 | -1.88 | Expensive |
| Debt to Assets | 0.13 | 0.48 | Cheaper |
| Market Cap | 85.67M | 3.71B | Emerging |
